Nontuberculous mycobacterial disease in children: A systematic review and meta-analysis
- PMID: 38845977
- PMCID: PMC11153170
- DOI: 10.1016/j.heliyon.2024.e31757
Nontuberculous mycobacterial disease in children: A systematic review and meta-analysis
Abstract
Background: The prevalence of nontuberculous mycobacterial (NTM) disease in children is increasing worldwide. The clinical manifestations of pediatric NTM patients are significantly different from those of adult patients, but the knowledge of the disease is generally poor.
Methods: English databases (PubMed, Web of Science, Embase, BIOSIS) and Chinese databases (CNKI, Wanfan, VIP) were searched on October 15th, 2022. All the articles of cross-sectional and cohort studies reporting the species composition and lesion site of the NTM disease in children using well-recognized NTM species identification methods were taken into account. Using a random effects model, we assessed the disease lesion sites and the prevalence of different NTM species in pediatric NTM disease. Sources of heterogeneity were analyzed using Cochran's Q and the I2 statistic. All analyses were performed using CMA V3.0.
Results: The prevalence rates of NTM disease in children ranged between 0.6 and 5.36/100,000 in different countries, and Europe reported the highest prevalence rate. The most common clinical lesion site was lymph node, accounting for 71.1 % (55.0 %-83.2 %), followed by lung (19.3 %, 9.8%-34.4 %)and then skin and soft tissue (16.6 %,13.5%-20.3 %). Mycobacterium avium complex (MAC) was the most isolated NTM pathogen in children, accounting for 54.9 % (39.4%-69.6 %). Inconsistent with adult patients, Mycobacterium avium accounted for a dominant proportion in MAC than Mycobacterium intracellulare.
Conclusions: The lymph node was the most affected organ in pediatric NTM disease, while Mycobacterium avium was the most isolated pathogenic species in children.
Keywords: Child; Clinical lesion sites; Nontuberculous mycobacteria; Species.
© 2024 The Authors. Published by Elsevier Ltd.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.Ann Am Thorac Soc. 2017 Jan;14(1):49-56. doi: 10.1513/AnnalsATS.201607-573OC. Ann Am Thorac Soc. 2017. PMID: 27788025
-
What do the clinical features of positive nontuberculous mycobacteria isolates from patients with HIV/AIDS in China reveal? A systematic review and meta-analysis.J Glob Health. 2023 Sep 1;13:04093. doi: 10.7189/jogh.13.04093. J Glob Health. 2023. PMID: 37651639 Free PMC article.
-
Trends in the Prevalence and Antibiotic Resistance of Non-tuberculous Mycobacteria in Mainland China, 2000-2019: Systematic Review and Meta-Analysis.Front Public Health. 2020 Jul 28;8:295. doi: 10.3389/fpubh.2020.00295. eCollection 2020. Front Public Health. 2020. PMID: 32850570 Free PMC article.
-
Prevalence and Clinical Characteristics of Nontuberculous Mycobacteria in Patients with Bronchiectasis: A Systematic Review and Meta-Analysis.Respiration. 2021;100(12):1218-1229. doi: 10.1159/000518328. Epub 2021 Aug 31. Respiration. 2021. PMID: 34515207
-
[Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].Kekkaku. 2013 Mar;88(3):355-71. Kekkaku. 2013. PMID: 23672176 Japanese.
Cited by
-
Analysis of nontuberculous mycobacterial infections in Saudi children from a tertiary care hospital perspective.J Clin Tuberc Other Mycobact Dis. 2025 Jul 26;41:100554. doi: 10.1016/j.jctube.2025.100554. eCollection 2025 Dec. J Clin Tuberc Other Mycobact Dis. 2025. PMID: 40837278 Free PMC article.
-
Targeting Autophagy as a Strategy for Developing New Host-Directed Therapeutics Against Nontuberculous Mycobacteria.Pathogens. 2025 May 13;14(5):472. doi: 10.3390/pathogens14050472. Pathogens. 2025. PMID: 40430792 Free PMC article. Review.
References
-
- Schoenfeld N., Haas W., Richter E., Bauer T., Boes L., Castell S., et al. Recommendations of the German central committee against tuberculosis (DZK) and the German respiratory society (DGP) for the diagnosis and treatment of non-tuberculous mycobacteria. Pneumologie. 2016;70(4):250–276. doi: 10.1055/s-0041-111494. - DOI - PubMed
LinkOut - more resources
Full Text Sources